DAVID F HALE Insider Trading $ONCT Oncternal Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID F HALE.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID F HALE. DAVID F HALE is Director in MICROMET, INC. ($MITI) and President and CEO in MICROMET, INC. ($MITI) and Chairman in BIOCEPT INC ($BIOC) and Director in BIOCEPT INC ($BIOC) and Director in SANTARUS INC ($SNTS) and Director in GTX INC /DE/ ($GTXI) and Director in METABASIS THERAPEUTICS INC ($MBRX) and Director in Pernix Sleep, Inc. ($SOMX) and Director in Conatus Pharmaceuticals Inc. ($CNAT).

DAVID F HALE in Oncternal Therapeutics, Inc.

Trading Symbol: ONCT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 699,406 shares
Current Value: $3,902,685
Latest Transaction: Jun 12 2020
$ONCT Market Capitalization: $86.92M
$ONCT Previous Close: $5.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DAVID F HALE in Oncternal Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BIOC, HSTO, MBRX, MITI, ONCT, SOMX, SNTS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 12 2020ONCTOncternal Therapeu ...HALE DAVID FDirectorOption ExerciseA2.9422,50066,15022,500
Sep 16 2019GTXIOncternal Therapeu ...HALE DAVID FDirectorOption ExerciseA5.7640,000230,40040,000
Jun 11 2019GTXIGTX INC /DE/HALE DAVID FDirectorOption ExerciseA6.133,29220,1803,292
Jun 11 2019GTXIGTX INC /DE/HALE DAVID FDirectorGrantA0.0018,346018,3460 to 18.3 K
Jun 11 2019GTXIGTX INC /DE/HALE DAVID FDirectorGrantA0.00699,4060699,4060 to 699.4 K

Page:   1